Impact of Ziwig Endotest® on the Management of Patients With Clinical Symptoms of Endometriosis Inconsistent With Their Imaging Work-up
Active, not recruitingNot applicableNCT06794424
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
The goal of this study is to evaluate the impact of Ziiwg Endotest on patient management decisions before and after the test. The main questions it aims to answer are: * Does the test reduce the intention and number of laparoscopies in women whose decision to undergo laparoscopy was made before the test result was obtained? * Does the test change management decisions in women with no prior indication for diagnostic laparoscopy? Study will compare the patient management decision before and after the test. The acts and procedures performed as part of this research are : * Aa saliva sampling (Ziwig Endotest) at inclusion * A mutidisciplinary meeting post test (if applicable) * Completion at inclusion and 6 month of a quality-of-life questionnaire (EHP-5) * Completion at inclusion and 6 month of a VAS for pain * Completion at inclusion and 6 month of a Likert satisfaction scale * A test results Announcement consultation * A visit at 6 months.
Study details
- Official title
- Impact of Ziwig Endotest® on the Decision and Management of Patients With Chronic Disabling Pelvic Pain Strongly Suggestive of Endometriosis and Presenting With a Negative or Uncertain Baseline Imaging Workup
- Conditions
- Interventions
- Diagnostic test: Ziwig Endotest®
- Sponsor
- ZIWIG
- Collaborators
- Monitoring Force Group
- Start date
- 2025-03-14
- Primary completion
- 2026-09-01
- Sex
- Female
- Age range
- from 18 Years to 43 Years
- Results posted
- No results posted in this snapshot
- Countries
- France
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: 1. Female aged 18 to 43 2. Strong clinical suspicion of endometriosis based on the following suggestive symptoms: chronic pelvic pain (\> 6 months) that is suggestive and disabling (ENA ≥ 8, absenteeism or resistance to level 1 analgesics) ± deep dyspareunia or painful hematuria/micturition with menstrual rhythm or painful rectal discharge/defecation with menstrual rhythm. 3. Endovaginal ultrasound and MRI (unless contraindicated, in which case only one of the 2 examinations is required\*) less than 1 year old and of sufficient quality , in compliance with the endometriosis protocol recommended by the HAS\*\*. 4. Clinical-radiological discrepancy confirmed by the investigating gynecologist and a referent radiologist at the investigating center, in compliance with the protocol's positivity criteria and the French ENDOVALIRM guidelines (for characterizing deep lesions on MRI) and/or the ESUR 2017 guidelines (for ovarian lesions) and/or the SUR-US 2024 guidelines (for ultrasound). 5. Woman has dated and signed the consent form. 6. Speaks and understands French 7. Affiliated with the French healthcare system Exclusion Criteria: 1. Endometriosis diagnosed according to imaging protocol positivity criteria 2. Differential diagnosis and/or adenomyosis made 3. History of isolated dysmenorrhea well controlled by hormonal contraception and no immediate desire for pregnancy, 4. Absence of pelvic pain strongly suggestive of endometriosis. 5. Isolated fatigue 6. Aetiological work-up incomplete or pending before deciding on initial medical decision (infertility work-up in progress, waiting for specialist opinion (algologist, psychologist, etc.), waiting for important test results), 7. Infertility work-up (current or previous), with no signs suggestive of endometriosis. 8. Search for recurrence of known endometriosis 9. Laparoscopy for gynecological reasons other than suspected endometriosis 10. History of cancer 11. Pregnant or breast-feeding women 12. Current bacterial or viral infection or less than one month old 13. Participation in an interventional study or in the exclusion period of an interventional study
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT06794424